HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease: Can we afford to do it? (Can we afford not to?).

AuthorsD V Exner, G J Klein, E N Prystowsky
JournalCirculation (Circulation) Vol. 104 Issue 13 Pg. 1564-70 (Sep 25 2001) ISSN: 1524-4539 [Electronic] United States
PMID11571253 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
Topics
  • Anti-Arrhythmia Agents (therapeutic use)
  • Canada (epidemiology)
  • Cardiomyopathy, Hypertrophic (therapy)
  • Complementary Therapies
  • Coronary Artery Bypass
  • Cost-Benefit Analysis
  • Death, Sudden, Cardiac (etiology, prevention & control)
  • Defibrillators, Implantable (economics, statistics & numerical data)
  • Germany (epidemiology)
  • Heart Arrest (therapy)
  • Heart Diseases (complications, economics, therapy)
  • Humans
  • Long QT Syndrome (therapy)
  • Multicenter Studies as Topic
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Tachycardia (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: